These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 35011321)
1. Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin. Abdalla AN; Di Stefano M; Poli G; Tuccinardi T; Bader A; Vassallo A; Abdallah ME; El-Readi MZ; Refaat B; Algarni AS; Ahmad R; Alkahtani HM; Abdel-Aziz AA; El-Azab AS; Alqathama A Molecules; 2021 Dec; 27(1):. PubMed ID: 35011321 [TBL] [Abstract][Full Text] [Related]
2. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells. Dinić J; Podolski-Renić A; Jovanović M; Musso L; Tsakovska I; Pajeva I; Dallavalle S; Pešić M Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527404 [TBL] [Abstract][Full Text] [Related]
3. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876 [TBL] [Abstract][Full Text] [Related]
4. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin. Li H; Krstin S; Wink M Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981 [TBL] [Abstract][Full Text] [Related]
5. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo. Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682 [TBL] [Abstract][Full Text] [Related]
6. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
7. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Li C; Guan X; Xue H; Wang P; Wang M; Gai X Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760 [TBL] [Abstract][Full Text] [Related]
8. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells. Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231 [TBL] [Abstract][Full Text] [Related]
9. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells. Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065 [TBL] [Abstract][Full Text] [Related]
10. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell. Li YS; Yang X; Zhao DS; Cai Y; Huang Z; Wu R; Wang SJ; Liu GJ; Wang J; Bao XZ; Ye XY; Wei B; Cui ZN; Wang H Eur J Med Chem; 2021 Apr; 216():113336. PubMed ID: 33725657 [TBL] [Abstract][Full Text] [Related]
12. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition. Gao M; Xu Y; Qiu L J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110 [TBL] [Abstract][Full Text] [Related]
13. Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites. Teng YN; Huang BH; Huang SY; Wu IT; Wu TS; Lee TE; Hung CC Biomed Pharmacother; 2021 Dec; 144():112379. PubMed ID: 34794239 [TBL] [Abstract][Full Text] [Related]
14. Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells. Zhong H; Zhao M; Wu C; Zhang J; Chen L; Sun J Eur J Med Chem; 2022 May; 235():114300. PubMed ID: 35339100 [TBL] [Abstract][Full Text] [Related]
15. Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities. Shawky AM; Abdalla AN; Ibrahim NA; Abourehab MAS; Gouda AM Eur J Med Chem; 2021 Jun; 218():113403. PubMed ID: 33823396 [TBL] [Abstract][Full Text] [Related]
16. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer. Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704 [TBL] [Abstract][Full Text] [Related]
18. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein. Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465 [TBL] [Abstract][Full Text] [Related]
19. A Y Wang Y; Jiang Z; Yuan B; Tian Y; Xiang L; Li Y; Yang Y; Li J; Wu A Biomater Sci; 2019 Nov; 7(11):4748-4757. PubMed ID: 31508613 [TBL] [Abstract][Full Text] [Related]
20. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]